![Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade | Neuropsychopharmacology Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-022-01416-z/MediaObjects/41386_2022_1416_Fig1_HTML.png)
Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade | Neuropsychopharmacology
![Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences](https://www.cell.com/cms/attachment/80bba834-8503-46c6-baf2-4d337398fb85/gr1.jpg)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
![Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist - Seira Doi, Tomohisa Mori, Naoki Uzawa, Takamichi Arima, Tomoyuki Takahashi, Masashi Uchida, Ayaka Yawata, Michiko Narita, Yasuhito Uezono, Tsutomu Suzuki, Minoru Narita, Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist - Seira Doi, Tomohisa Mori, Naoki Uzawa, Takamichi Arima, Tomoyuki Takahashi, Masashi Uchida, Ayaka Yawata, Michiko Narita, Yasuhito Uezono, Tsutomu Suzuki, Minoru Narita,](https://journals.sagepub.com/cms/10.1177/1744806916654146/asset/images/large/10.1177_1744806916654146-fig4.jpeg)
Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist - Seira Doi, Tomohisa Mori, Naoki Uzawa, Takamichi Arima, Tomoyuki Takahashi, Masashi Uchida, Ayaka Yawata, Michiko Narita, Yasuhito Uezono, Tsutomu Suzuki, Minoru Narita,
![Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist](https://www.naabt.org/images/tech_2.jpg)
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
![Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics](https://jpet.aspetjournals.org/content/jpet/365/1/37/F1.large.jpg)
Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
![Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor | Molecular Pharmacology Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor | Molecular Pharmacology](https://molpharm.aspetjournals.org/content/molpharm/98/4/475/F1.large.jpg)
Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of µ-Opioid Receptor | Molecular Pharmacology
![Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective](https://www.frontiersin.org/files/MyHome%20Article%20Library/551365/551365_Thumb_400.jpg)
Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
Methadone and fentanyl selectively activate mu-delta opioid receptor... | Download Scientific Diagram
![Pharmacy | Free Full-Text | The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review Pharmacy | Free Full-Text | The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review](https://pub.mdpi-res.com/pharmacy/pharmacy-10-00048/article_deploy/html/images/pharmacy-10-00048-ag.png?1650444780)
Pharmacy | Free Full-Text | The Potential of Methocinnamox as a Future Treatment for Opioid Use Disorder: A Narrative Review
![Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling Structural Assessment of Agonist Efficacy in the μ-Opioid Receptor: Morphine and Fentanyl Elicit Different Activation Patterns | Journal of Chemical Information and Modeling](https://pubs.acs.org/cms/10.1021/acs.jcim.0c00890/asset/images/medium/ci0c00890_0010.gif)